Therefore, PTX3 down-regulation could be part of a TGF-β1 regulatory program leading to fibrinolysis inhibition and ECM increased deposition, both determinants of IPF pathogenesis and progression. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.